JPS58157469A - Resin composition for medical device - Google Patents
Resin composition for medical deviceInfo
- Publication number
- JPS58157469A JPS58157469A JP57041889A JP4188982A JPS58157469A JP S58157469 A JPS58157469 A JP S58157469A JP 57041889 A JP57041889 A JP 57041889A JP 4188982 A JP4188982 A JP 4188982A JP S58157469 A JPS58157469 A JP S58157469A
- Authority
- JP
- Japan
- Prior art keywords
- oxide
- vinyl acetate
- ethylene
- weight
- vinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011342 resin composition Substances 0.000 title description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 36
- 229920001577 copolymer Polymers 0.000 claims description 33
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 16
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- 229920005989 resin Polymers 0.000 claims description 12
- 239000011347 resin Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 10
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000292 calcium oxide Substances 0.000 claims description 9
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 9
- 229910002090 carbon oxide Inorganic materials 0.000 claims description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 6
- 239000005977 Ethylene Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 239000008280 blood Substances 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 21
- 230000003013 cytotoxicity Effects 0.000 description 10
- 231100000135 cytotoxicity Toxicity 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 206010018910 Haemolysis Diseases 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 6
- 230000008588 hemolysis Effects 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000003381 stabilizer Substances 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- -1 for example Substances 0.000 description 5
- 238000000465 moulding Methods 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000000395 magnesium oxide Substances 0.000 description 4
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 4
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical class C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 229920006163 vinyl copolymer Polymers 0.000 description 2
- 229920001567 vinyl ester resin Polymers 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical class CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- RTNBXJBOAIDPME-SHUUEZRQSA-N 8-phospho-3-deoxy-D-manno-oct-2-ulosonic acid Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CC(=O)C(O)=O RTNBXJBOAIDPME-SHUUEZRQSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000004709 Chlorinated polyethylene Substances 0.000 description 1
- 229920003314 Elvaloy® Polymers 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 241000282346 Meles meles Species 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- INLLPKCGLOXCIV-UHFFFAOYSA-N bromoethene Chemical compound BrC=C INLLPKCGLOXCIV-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- OKTJSMMVPCPJKN-BJUDXGSMSA-N carbon-11 Chemical compound [11C] OKTJSMMVPCPJKN-BJUDXGSMSA-N 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- LBFQRRCJZWXVNE-UHFFFAOYSA-N dichloromethane;ethenyl acetate Chemical compound ClCCl.CC(=O)OC=C LBFQRRCJZWXVNE-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- XUCNUKMRBVNAPB-UHFFFAOYSA-N fluoroethene Chemical compound FC=C XUCNUKMRBVNAPB-UHFFFAOYSA-N 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical group [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- External Artificial Organs (AREA)
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
本発明は医療器材、411K輪筐保存用パツダ、血液保
存容器、人工腎momiia路用チェープ等を構成す為
に適しえ樹ll綴虞−に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a tree binding device suitable for constructing medical equipment, a 411K ring housing storage pad, a blood storage container, an artificial kidney tract chain, and the like.
従来、医療用器材として例えば血液を運搬した9保存す
るために血液バッグが使用され、又腎臓障害の患者に対
し人工腎臓による透析を行なうに際し、血液回路用チュ
ーブが使用される。BACKGROUND ART Conventionally, blood bags have been used as medical equipment, for example, to transport and store blood, and blood circuit tubes have been used when performing dialysis using an artificial kidney for patients with renal failure.
そしてこれらKII求される性質社柔軟であって変質せ
ず、血液と永く接触しても血液を変質させたり、血液中
に異物を移行させ丸〉するものであってはならない。
又、血11i路用テエープは、内部を通過する血液を外
側から観察で―るr!1男性と、自在に変形しうる柔軟
性、チェープの外側からタツングで締付は丸〉外しえ)
する際にチューブが遮ヤかに元O影状E1m復し、この
操作によって血流を随時止め丸)#lし丸)することが
できる反檎弾性、テエープを巻付けたや積重ねたヤしえ
@にチューブ同志が、癒着したりすることがない表面の
非粘着性等が要求される。The required properties of these KIIs are that they must be flexible and not change in quality, and even if they come into contact with blood for a long time, they must not change the quality of blood or transfer foreign substances into the blood.
In addition, the blood 11i tract tape allows you to observe the blood passing inside from the outside! 1. Flexible enough to be freely deformed, tightened by tightening from the outside of the chain (round)
When the tube is shielded, the tube returns to its original O shadow shape, and by this operation, the blood flow can be stopped at any time. In addition, a non-adhesive surface is required to prevent the tubes from adhering to each other.
従来塩化ビニル樹脂に可閣剤としてジオタチルフタレー
ト (以下DOPと称す)を添加し九組成物から、例え
ば血1[0這搬、保存の丸めO皇液バッグ、人工透析の
丸めの皇濠回路用テエープ等の医療器材が成形加工によ
)Iられてきえ。Conventionally, diotatylphthalate (hereinafter referred to as DOP) is added as a detergent to vinyl chloride resin, and from the nine compositions, for example, blood 1 [0] is collected, a rounded liquid bag for preservation, a rounded liquid bag for artificial dialysis, etc. Medical equipment such as circuit tapes can be molded.
しかし傘がら塩化ビニル樹脂KDOPを添加し九組成物
は、DOPが血箪中Ell出し、人体に悪影響を及ぼす
懸念がありえ。こOよう傘欠点を震消すゐ為に411[
1154−11@I@i1号(特開185@−41!4
0号)において、塩化ビニル系樹脂にエチレン・−酸化
炭素・酢酸ビニに共重合体と、酸化カルシウム又は酸化
!グネシクム01111車を所定量配置しえ医療器材用
樹脂組成物を提察しえ◎
しかし象からエチレン・−酸化炭素・酢酸ビニル共単量
体中には、ζO共重金体O分解によ襲生じえ酢酸が存在
してお)、ζoIIll脂組威物を用いて医療器材を成
形し丸場合に、瀉血性、細胞毒性を示す原因に1に:b
ことがわかつlI−o * ’hる酢lIO発生量が龜
わめて少量O場合には銀酸物中OII化カルシクム又は
酸化マダネシウムO黴看末によって!III捉すること
がで亀るが、l1lIIIO量が多く1為と組成物中O
酸化′IIルシウム又!酸化マグネシウムaSS末によ
って鉱捕捉し切れないものとな〉、成形物OII血性、
細胞毒性は避轢離い。酢酸を捕捉するえめに組成物中の
酸化カルシウム又は酸化!グネシクムO黴粉末の量を増
加させれば威彫物社透amが低下し、強熱残量が増加し
、医療器材用基準値を越えてしまうおそれが生ずる。However, in the case of compositions containing vinyl chloride resin KDOP, there is a concern that DOP will be released into the blood chamber and have an adverse effect on the human body. 411 to eliminate the shortcomings of this umbrella.
1154-11@I@i1 (JP-A-185@-41!4
No. 0), a copolymer is added to vinyl chloride resin, ethylene-carbon oxide, vinyl acetate, and calcium oxide or oxidation! Arrange a predetermined amount of Gnesicum 01111 and propose a resin composition for medical equipment. If acetic acid is present), ζoIIll fat composition is used to mold medical equipment, causing bloodletting and cytotoxicity.
It turns out that if the amount of vinegar generated is extremely small, use calcium oxide or madanesium oxide in silver oxide as a final precaution! Although it is possible to capture IIIO, the amount of O in the composition is large and O
Lucium oxide 'II! The ore cannot be completely captured by the magnesium oxide aSS powder.
Avoid cytotoxicity. Calcium oxide or oxidation in the composition to scavenge acetic acid! If the amount of Gunesicum O mold powder is increased, the Ichomonosha transparency am will decrease, the residual amount of ignition will increase, and there is a possibility that the standard value for medical equipment will be exceeded.
本発明はこのような点に−み、更に一意検討を加えた結
果なされ丸発明であ)、そO要旨とするところは、塩化
ビニル系樹脂と、エチレン拳−酸化巌嵩・酢酸ビニル共
重合体を書査する組IIL物において、エチレン・−酸
化炭素・酢酸ビニル共重合体として、エチレンe−酸化
炭嵩e酢績ビニル共重合体に対して溶解性がなく酢酸に
対して溶解性がある液体によ〉予じめ部層したものを使
用することを特徴とする、医療器材用樹脂組成−に存す
る。In view of these points, the present invention was made as a result of further unique studies. In the group IIL substance for which coalescence is investigated, as an ethylene-carbon oxide-vinyl acetate copolymer, it has no solubility in ethylene-e-carbon oxide-vinyl acetate copolymer and is soluble in acetic acid. The present invention relates to a resin composition for medical equipment, which is characterized in that it is preliminarily coated with a certain liquid.
次に本発明医療器材用樹脂組成物に′)いて更に詳細に
説明する。Next, the resin composition for medical equipment of the present invention will be explained in more detail.
本発明で用いられる塩化ビニル系樹脂は、塩化ビニルO
I#独重合体に@もず、塩化ビニルO共重合体であって
−よい。塩化ビニルO共重合体としては、塩化ビニルと
倫の単量体とを共重合させてII丸共重合体Oほか、働
O重会体又は共重合体に、塩化ビニルをダツット重金さ
せて得たグラフト重合体をも用いることがで亀ゐ〇上述
の傭の単量体としては、エチレン、プロピレン等Oα−
オレフィンa、saビニ慶、ステアリン駿ビニル畳のビ
ニルエステル類、メチルビニルエーテル、竜チルビニル
エーテル等のビニルエーテル類、臭化ビニル、弗化ビニ
# @ 0ハロダ/化ビニル類、ivイン鐵、無水マレ
イン瞭、フマル酸、111IO不飽加酸−1lびこれら
Oエステル類、スチレン、アタリ−ニトリル、塩化ビニ
リデン勢を挙げることがで龜る・ダラ7ト共重會体O幹
となる単量体又は共重合体としては、塩素化ポジエチレ
ン、エチレン−酢酸ビニル共重合体、エチレン−ブーピ
レン共重合体を挙けることがで龜る。さらに塩化ビニル
樹脂を後塩素化して得え、塩素化塩化ビニルll1l1
1−便用できる。The vinyl chloride resin used in the present invention is vinyl chloride O
The I# monopolymer may be a vinyl chloride O copolymer. Vinyl chloride O copolymers include II round copolymer O obtained by copolymerizing vinyl chloride and a monomer of Rin, and vinyl chloride obtained by copolymerizing vinyl chloride with a working O polymer or copolymer. Graft polymers can also be used. Examples of the above-mentioned monomers include Oα-
Olefin a, sa vinyl esters, stearin vinyl esters, vinyl ethers such as methyl vinyl ether, dragon chill vinyl ether, vinyl bromide, vinyl fluoride, iv iron, maleic anhydride, etc. , fumaric acid, 111IO unsaturated acid-1l and their O esters, styrene, atarynitrile, and vinylidene chloride can be mentioned. Examples of the polymer include chlorinated polyethylene, ethylene-vinyl acetate copolymer, and ethylene-bupylene copolymer. Furthermore, it is obtained by post-chlorinating vinyl chloride resin, and chlorinated vinyl chloride ll1l1
1- Can be used for stool.
しかしながら塩化ビニル系樹脂は、成形物として柔軟性
を欠くものと&jl、そOt〜では血液バッグ、血液回
路用チェープ等O柔軟性を必要とする医療−一用成形物
として適しえものが得られない。この丸め柔軟性を付与
するに社、ジオクチル7タレート勢の可■剤を加えるこ
とが(−
行なわれてき友が、可−剤の溶出による毒性が大きな問
題となる。However, vinyl chloride resin lacks flexibility as a molded product, and it is not suitable for medical molded products that require flexibility, such as blood bags and blood circuit tapes. do not have. In order to impart this rounding flexibility, it has been attempted to add a dioctyl 7-talate type stabilizer, but toxicity due to elution of the binder poses a major problem.
そこで本発明では、可閣剤を加えることなく、成形物に
柔軟性を付与し、しかも透明性を高度に保持しうる一〇
とする丸めに、エチレン・−酸化炭素・酢酸ビニル共重
合体を配食する。本発明で用いられるエチレン・−酸化
炭素・酢酸ビニル共重合体は例えばデュポン社製[エル
バロイ741J勢が市販されているが、これらを含めて
1重量部のエチレンに対しくLl)!乃至0.5重量部
の一酸化炭素と0.1乃至0.9重量部の酢酸ビニルを
共重合させたもOである。エチレン・−酸化炭素・酢酸
ビニル共重合体社塩化ピ二ル系樹脂100重量部に対し
5乃至!O・重量部0111合で使用するのが好適であ
る〇しかしながらエチレン・−酸化炭素・酢酸ビニル共
重合体中Ka分解によ)生じた酢酸が含有されているこ
とが多く、そO★\壊化ビニル系樹脂と配合しえ組成物
を用いて成形物を成形すると酢酸ビニルはそOま〜成形
物中に存在して溶血性及び細胞毒性の原因物質と*)、
[蒸器材用としてO適性を喪失させ為おそれがある。Therefore, in the present invention, we have added an ethylene-carbon oxide-vinyl acetate copolymer to the 10 round shape that can impart flexibility to molded products and maintain a high degree of transparency without adding a binder. Distribute meals. The ethylene/carbon oxide/vinyl acetate copolymer used in the present invention is, for example, manufactured by DuPont Co. [Elvaloy 741J is commercially available; O is a copolymer of 0.5 to 0.5 parts by weight of carbon monoxide and 0.1 to 0.9 parts by weight of vinyl acetate. Ethylene-Carbon Oxide-Vinyl Acetate Copolymer Co., Ltd. 5 to 100 parts by weight of pynylic chloride resin! It is preferable to use it at 0.111 parts by weight.However, it often contains acetic acid produced (by decomposition of Ka in the ethylene-carbon oxide-vinyl acetate copolymer), When a molded article is molded using a composition blended with a vinyl chloride resin, vinyl acetate is present in the molded article and becomes a causative agent of hemolysis and cytotoxicity*).
[There is a risk of losing O suitability for use in steam equipment.
ところで成形物中に酸化カルシクム徽驕末、酸化マグネ
シウム黴粉末が含有されていると、酢酸を捕捉すること
かで龜る◎しかしながら酢酸の量が酸化j iay s
/9ム徽験末中酸化!ダ専シクム黴看末によJ11捕捉
能力を越えるもOである場合Kti虞形物轄溶皇性、4
11ml毒性を示し、阪療器材用として適性を有し′&
い40と亀る。こO対策として酸化カルシウム黴看末、
酸化マグネV9ム黴輪末O量を増−することも考えられ
為が、この場合は成形物earsが低下し、又、強熱幾
分が医療IH1における規制値よ)も高くなる等の弊害
を生ずるので、多量の酸化カルシウム微粉末、酸化iグ
ネシクム微粉末O使用は適切でない。By the way, if calcium oxide powder or magnesium oxide mold powder is contained in the molded product, the amount of acetic acid is increased by capturing acetic acid. However, the amount of acetic acid is
/ Oxidation at the end of the 9th trial! If the J11 capture ability is exceeded in the end, there is a possibility that the J11 capture capacity will be exceeded.
11ml exhibits toxicity and is suitable for use in Osaka therapy equipment.
I'm 40. Calcium oxide mold treatment is used as a countermeasure against this disease.
It may be possible to increase the amount of mold ring powder O in Magne oxide V9, but in this case, the molded product's ears will decrease, and the ignition temperature will also be higher than the regulation value in medical IH1. Therefore, it is not appropriate to use a large amount of calcium oxide fine powder or i-gnesicum oxide fine powder O.
そこで本発明において社、エチレン−一酸化炭木・酢酸
ビニル共重合体として、エチレン・−酸化炭素・酢酸ビ
ニル共重合体に対して溶解性がなく、酢酸に対して溶解
性がある液体により予しめ処理し丸ものを使用するので
ある。Therefore, in the present invention, the ethylene-carbon monoxide-vinyl acetate copolymer is pre-prepared with a liquid that is insoluble in the ethylene-carbon oxide-vinyl acetate copolymer but soluble in acetic acid. We use round ones that have undergone a tightening process.
前記液体としては水が好適であるが、そO他に例えば次
の液体が単独でもしくは混合されて使用される。Although water is suitable as the liquid, the following liquids may be used alone or in combination.
アルコール系;メタノール、エタノール、a−プロピル
アルコール、インプ費ビル
アルコール、エタノール
クトン系;アセトン、メチルイソブチルケトン、メチル
エチルケトン
エステル系;酢酸エチル、酢酸ブチル
縦化水嵩畢;ブタン、べ/タン、ヘキサノ、/クロヘキ
ナン、ベンゼン、中シレン、トルエン
ハ四ゲン化員化水嵩系;塩化ビニル、7レオン、クロロ
ホルム、四塩化炭素、トリ
クレン
そO傭;ジオ命ナン、ジメチルホルムアミド、セーソル
ブ等
前記液体と011!触社、前記共重合体を粒状0ま\又
紘必要に応じて粉砕しえ一〇を用いて前記筐体中に浸漬
するとか、前記筐体を水で希釈するか水に分散させた4
0に浸漬する等が好適である。Alcohols: methanol, ethanol, a-propyl alcohol, alcohol, ethanol, acetone, methyl isobutyl ketone, methyl ethyl ketone esters; ethyl acetate, butyl acetate; butane, be/thane, hexano, / Chlohequinane, benzene, middle silane, toluene, tetragenated water bulk system; vinyl chloride, 7-leon, chloroform, carbon tetrachloride, trichlene, dionene, dimethylformamide, sesolv, etc. and 011! Alternatively, the copolymer may be pulverized in granular form and immersed in the casing using a sieve, or the casing may be diluted with water or dispersed in water.
It is preferable to immerse the liquid in water at 0.
前記共重合体と前記筐体とO錬触温111紘前記員重會
体O二次転移温度よ〉も低い温度域に調整され為Oが好
適であ)、又接触時間は数分り至歇時闘S*とされるO
が好適である。The contact temperature between the copolymer and the casing is adjusted to a temperature range lower than the second order transition temperature of the member polymer, so O is preferable), and the contact time is several minutes. O is considered to be Jito S*
is suitable.
前記共重合体と前記液体を接触させることによ)、成形
物中に存在している酢酸ビニルが濤出される。そして前
記共重合、体中に存在する酢酸ビニルが連出されること
によ)II皇性、細胞毒性を示′s1にいもOとを為。By bringing the copolymer into contact with the liquid, the vinyl acetate present in the molded article is washed out. During the copolymerization, vinyl acetate, which is present in the body, is released, resulting in cytotoxicity.
洗滌が十分に行なわれ丸か否か紘最終約に&i總成物を
用いて実際に成形を行ない、そ0威形物について溶血性
試験、細j!!壽性試験を行って決められるが、大体の
I安としては、洗滌IfOPH値を測定し、これと溶血
性試験、細胞毒性試験との相関を得てPH値から判断す
ることができる。After thorough washing, we actually molded the composite material to determine whether it was round or not, and conducted a hemolytic test on the shape. ! Although it can be determined by carrying out a durability test, the approximate I-animal value can be determined from the PH value by measuring the washed IfOPH value and correlating this with the hemolysis test and cytotoxicity test.
洗滌を繰返し行なつ先後、乾燥を打電い、有機溶剤等が
残存しないよう熱的処置、真空乾燥処理勢が施される。After repeated washing, electric drying is performed, and thermal treatment and vacuum drying treatment are applied to ensure that organic solvents and the like do not remain.
塩化ビニル系樹脂と、エチレン・−酸化炭嵩轡酢鹸ビニ
ル員重金体から象る組成物は、柔軟性、透明性の向で医
療S材用組成物として好ましい性實をもつ一〇であるが
、諌組成物が更に酸化マグネシウム黴粉末又社(及び)
酸化カルシウム像粉末を含有す為ととによって、上記溶
血性及び細胞毒性が抑制される。A composition consisting of a vinyl chloride resin and an ethylene-oxycarbonated bulk vinegar vinyl-membered heavy metal body has desirable properties as a composition for medical S materials in terms of flexibility and transparency. However, the composition is further refined by magnesium oxide mold powder (and)
By containing calcium oxide image powder, the above-mentioned hemolysis and cytotoxicity are suppressed.
この場合の酸化マダネシ9ム微粉末、酸化カルシウム微
粉末は倒れ450戸以下OSmを有するものであること
が望ましい。In this case, it is desirable that the fine powder of Madanea 9um oxide and the fine powder of calcium oxide have an OSm of 450 or less.
酸化マグネシウム黴粉末、酸化★ルタタ^黴粉末は、鋏
塩化ビニル系樹脂100重量部轟伽、00051いし5
重量no範閤O比率で加えられることが望ましい。Magnesium oxide mold powder, oxidized Rutata mold powder, 100 parts by weight of vinyl chloride resin, 00051 to 5
It is desirable to add it in a weight ratio.
更に、本発WAにおりる組成物の鵬安定性、耐老化性を
改畳す為えめに、血液41に有書亀影響を及ばさ倉い範
囲角で、安定剤中可■剤を腋龜威物中に配合することが
で自る。Furthermore, in order to improve the stability and aging resistance of the composition contained in the present WA, the stabilizing agent was added to the armpit in a range that would have a negative effect on the blood. It is possible to mix it into the ingredients.
安定剤としては例えば、ステアジノ酸カルシクム、ステ
アV/駿亜鉛、ステアシン酸パシウム勢で61可閣剤と
してはエポ中V化大豆油、ジオタチルックレート勢を用
いJhことがで龜る。As the stabilizer, for example, calcium stearate, stear V/zinc, and pacium stearate can be used, and as the stabilizing agent, V-containing soybean oil in EPO and diotatilucrate can be used.
本発明における組成物は上記し九機に塩化ビニル系樹脂
と、エチレンーー酸化嶽嵩−酢駿ビニル共重会体七會有
し、該共重合体として、陳貢重会体に対して溶解性がな
く酢酸に対して溶解!!kが−る液体によ〉予じめ電層
しえ一〇を使用することによ)、腋共重舎体中に存在す
る酢酸を除去しえものを用いるOで、皺共重会体中O酢
酸に起因する溶血性、細胞毒性を龜えさないものとする
ことがで龜る。The composition of the present invention contains the above-mentioned nine vinyl chloride resins and seven ethylene-oxidized vinyl copolymers, and these copolymers are soluble in the Chen Gong polymer. Not soluble in acetic acid! ! The acetic acid present in the axillary copolymer body can be removed by using a liquid containing an electrolyte (by using an electrolytic layer 10), and the wrinkled copolymer body This makes it possible to avoid hemolysis and cytotoxicity caused by medium-O acetic acid.
本発明ではこのようにして得られ九組成物を用いて所望
の形状の成形物を成形すゐ。成形物の形状は、フィルム
状、シート状、板状、客器状、管状、筒状、棒状、袋状
、その他任意O形状であって、目的とする医療器ItO
111IIKよ拳法められる。成形には押出成形、射出
成形、#l砥成形、プレス成形、吹込威彫等O通富Oj
l形手段を採用で龜る。In the present invention, the thus obtained composition is used to mold a molded article into a desired shape. The shape of the molded product may be a film, sheet, plate, container, tube, tube, rod, bag, or any other O shape, and the shape is suitable for the intended medical device ItO.
111 IIK is accused of kenpo. Molding includes extrusion molding, injection molding, #l grinding molding, press molding, blowing engraving, etc.
Adoption of L-shaped means increases the speed.
成形時の銀皺としては110℃〜111G’C1i度と
されるのが好ましく、塩化ビニル系樹層、エチレン・−
酸化炭素・酢酸ビニル共重合体O熱分解を抑制する丸め
に110℃〜140℃O温度範囲で成形することが最も
好ましい。It is preferable that the silver wrinkles during molding be 110°C to 111G'C1i degrees.
It is most preferable to form the carbon oxide/vinyl acetate copolymer O into a round shape at a temperature range of 110° C. to 140° C. to suppress thermal decomposition.
かくして得られた医療器材用成形−社、そのままで又は
二次加工を施すことによ)、カテーテル、輸血中軸淑用
C)fエーゾ、血涼パツダ、輸液バッグ勢O医療器#に
好適に用いることができるものである。The thus obtained molded product for medical equipment is suitable for use as it is or by secondary processing), catheters, blood transfusions, C) f-Eso, blood transfusion bags, and other medical devices. It is something that can be done.
本発明方法により得られる医療器材用成形物によれば、
柔軟性、透@性に優れ、溶血性、細胞胞毒性を示さず、
しかも耐ブーツ中ンダ性が改曹されえ医療器材を得ゐこ
とがで龜ゐ@以下に本発明O実施例を挙が為。1にシ、
−血性試験は日本*局方「一般試験渋J4C1*0輪箪
用Oプラスチック容器試験法に準拠して行なっI−O
実施例1
粉末状Oエチレン・−酸化炭素・酢酸ビニル員重会体1
00重量部に対し、水3・0重量部を用い、攪拌器付容
器の中で型温で60分関a件しえ。According to the molded article for medical equipment obtained by the method of the present invention,
Excellent flexibility and permeability, shows no hemolysis or cytotoxicity,
In addition, the resistance to dirt in boots can be improved and medical equipment can be obtained.Examples of the present invention are listed below. 1 to shi,
- The blood test was conducted in accordance with the Japanese *Pharmacopoeia ``General Test Shibu J4C1 * Test method for O plastic containers for O-wheeled cabinets''.
Using 3.0 parts by weight of water to 0.00 parts by weight, heat in a container with a stirrer at mold temperature for 60 minutes.
次いでこれを脱水乾燥しえもOKついて、輪濠用プラス
チツタS器試験法に基づいて測定し九PH値はIL5で
参りえ。Next, it was dehydrated and dried, and the pH value was measured based on the ring moat plastic S instrument test method, and the pH value was IL5.
一方上記O洗滌におけ為水中へO涛出物O量は麹記共重
會体に対しくL1重量−で番りえ。On the other hand, in the above O washing, the amount of O spilled out into the water is expressed as L1 weight for the Kojiki copolymer.
次にこOエチレン・−酸化炭素11ビニに^重会体を用
いて下記の組成物を得え。Next, use the ethylene/carbon 11 vinyl polymer and the polymer to obtain the following composition.
酸化マグネンウム Q、5重量部カ
ルシウム・亜鉛系安定剤 16重量部エポキ
シ化大豆油 2.0重量部上記の組
成物を押出機で*m混練し、ペレットを作成し友。Magnenium oxide Q, 5 parts by weight Calcium/zinc stabilizer 16 parts by weight Epoxidized soybean oil 2.0 parts by weight The above composition was kneaded using an extruder to form pellets.
次いでシート成形機にて厚さ0.3■OシーF状成形物
を得九。このシート状威拳物は、透明性、柔軟性がすぐ
れ、溶血性は一〜土であ〉、又細胞毒性を示すことがな
く、強熱残分を片4重量−でm徹セット用基準内O値を
示しえ。Next, a sheet molding machine was used to obtain an F-shaped molded product with a thickness of 0.3 cm. This sheet-like material has excellent transparency and flexibility, has a hemolytic property of 1 to 30%, and does not exhibit cytotoxicity. Show the O value within.
又、耐ブーツキ/ダ性も嵐好であった・このシート状成
形物1皇濠バツグ用シートとして好適であった。In addition, the boot scratch/dust resistance was also good.This sheet-like molded product 1 was suitable as a sheet for Komo bag.
実施例2
樹木状のエチレン・−酸化炭素・酢酸ビニル共ム合体1
00重量部に対し、メタノール200mm部を用い、攪
拌器付容器の中で型温で60分閏攪拌し、乾燥しえもO
Kついて輪濠用プラスナック容器試験法に基づいて測定
し九PHa龜Oで溶出物O量は前記共重合体に対し10
重量−でありえ。Example 2 Tree-like ethylene-carbon oxide-vinyl acetate co-merge 1
00 parts by weight, 200 mm parts of methanol was stirred for 60 minutes at the mold temperature in a container with a stirrer, and dried shimo
K was measured based on the ring moat plastic snack container test method, and the amount of eluate O at 9 PHa pot O was 10
Weight - can be.
&にこOエチレン・−酸化炭素・酢酸ビニル共重合体を
用いて、実施例1と岡じ親戚物を作威し、実施例1と同
様にしてシート状成形物を得丸。このシート状成形物は
透明性、柔軟性がすぐれ、溶血性、細胞毒性を示すこと
がなく、強熱残分もQ、4重量−で皇箪竜ツ)用基阜内
O値を示しえ。又耐ブロッキング性も良好であつえ・こ
Oシート状成形物紘、血液バッダ用シートとして好適亀
もOであつ丸。A similar product to that of Example 1 was produced using ethylene/carbon oxide/vinyl acetate copolymer, and a sheet-shaped molded product was obtained in the same manner as in Example 1. This sheet-like molded product has excellent transparency and flexibility, does not exhibit hemolysis or cytotoxicity, and has a residue on ignition of Q, and exhibits a standard O value of 4 by weight. . It also has good blocking resistance and is suitable for use as a sheet-like molded sheet for blood badgers.
実施例3
粉末状Oエテレ/・−酸化炭素・**ビニル員重会体1
00重量部に対し、本20・重量部、塩化ビニル11部
りa舎濠を用い、攪拌器付**0中で25℃で60分間
攪拌し、乾燥しえもOについて輪濠用プラスチック容器
試験妹に基づいて一定しえPH&i@Llで溶出物O量
紘前記共重会体KmIL張1m1−であつ九0法にこの
エチレン・−酸化炭素・酢酸ビニル共1合体を用いて、
実施例1と同じ組成物を作威し、実施例1と同様にして
シート状成形物を得九。このシート状成形物は透明性、
柔軟性がすぐれ、#I嵐性、細胞毒性を示すことが亀(
、強熱残分もQ、4重量−で血液セット用基準内O値を
ボしえ0又耐ブロツキング性も良好であつ良。Example 3 Powdered O etele/-carbon oxide/**vinyl member polymer 1
00 parts by weight, 20 parts by weight of books, 11 parts of vinyl chloride, stirred for 60 minutes at 25°C in a stirrer equipped with a **0, and tested the plastic container for a ring moat for dry Chiemo O. Using this ethylene-carbon oxide-vinyl acetate copolymer in the 90-method, the amount of eluate O at a constant PH & i@Ll was set at 1 ml of the above copolymer KmIL.
The same composition as in Example 1 was used and a sheet-shaped molded product was obtained in the same manner as in Example 1. This sheet-like molded product has transparency,
Turtles have excellent flexibility, #I storm properties, and cytotoxicity.
Also, the ignition residue exceeds the O value within the blood set standard at Q, 4 weight - 0, and the blocking resistance is also good.
このシート状成形物は、血液バッグ用シートとして好適
なものであつえ。This sheet-like molded product is suitable as a blood bag sheet.
実施例4
粉末状のエチレン・−酸化炭素・酢酸ビニル共重合体1
00重量部に対し、水200重量部、アセトン10重量
IIO混合液を用い、攪拌器付容器O中で25℃で60
分間攪拌し、乾燥しえものKついて輪箪用グツスチツタ
容器試験法に基づいて測定し九PHはL8で溶出物O量
は前記共重合体に対しa・重量%でありえ0次にこのエ
チレン・−酸化嶽素−酢酸ビニル共N會体を用いて、実
施例1と同じ組成物を作成し、実施例1と一1lKして
シート状成形物を得え。こOシート状成形物社逓−性、
柔軟性がすぐれ、溶血性、細胞毒性を示すことが愈く、
強熱残分も0.4重量−で血濠セット層基阜内の値を示
しえ。叉耐プロツキンダ性も良好であった。Example 4 Powdered ethylene-carbon oxide-vinyl acetate copolymer 1
00 parts by weight, 200 parts by weight of water, 10 parts by weight of acetone, and 60°C at 25°C in a container O with a stirrer.
Stir for 1 minute, then measure the dry raw material K based on the test method for a rotary container.The 9PH is L8, and the amount of eluate O is a% by weight based on the copolymer. A composition similar to that of Example 1 was prepared using a dichloromethane-vinyl acetate co-N, and a sheet-like molded product was obtained by adding 11K to Example 1. Flexibility of sheet-shaped molded product,
It has excellent flexibility and does not exhibit hemolytic or cytotoxic properties.
The ignition residue also shows a value of 0.4 weight - within the blood moat set layer base. The scratch resistance was also good.
こOシート状成形物は、皇筐バッダ用シートとして好適
&もOでありえ◎
実施例5
粒状Oエチレン・−酸化炭素・酢酸ビニル共重合体10
0重量部に対し、氷雪・・重量部、塩化ビニルS]ll
[llO温會濠を用い攪拌器付**0中で40℃で60
分間攪拌し、11L鍮し九%OKついて輪濠用プラスチ
ツタ審器試験淡に基づいて一定しえpua龜S″ciI
出物O量は前記共重合体KILL!Jall−であり1
IIl!e次にこOエチレン・−酸化炭素11ビニに共
重合体を用いて、実施例1と同じ親戚物を作威し、実施
例1と同様にしてシート状成形物を得え。ζOレシート
成形物は透明性、柔軟性がすぐれ、瀉血性、Jllll
Il毒性を示すことがなく、強熱残分も0.4重量−で
皇筐竜ット用基皐内の値を7J<シた。又耐ブロッキン
グ性も良好であつ九。This O sheet-like molded product is suitable as a sheet for the imperial cabinet badder. Example 5 Granular O ethylene/carbon oxide/vinyl acetate copolymer 10
0 parts by weight, ice and snow...parts by weight, vinyl chloride S]ll
[60°C at 40°C in **0 with a stirrer using a warm moat
Stir for 11 liters, then adjust to 9% OK based on the test results for ring moat plastics.
The amount of output O is the copolymer KILL! Jall-de 1
IIl! Next, prepare the same relative as in Example 1 by using this ethylene/carbon oxide 11 vinyl copolymer, and obtain a sheet-like molded product in the same manner as in Example 1. ζO receipt molded product has excellent transparency, flexibility, bloodletting properties, and
It did not show Il toxicity, and the ignition residue was 0.4% by weight, which was less than 7J. It also has good blocking resistance.
このノート状成形物は、血液パツダ用として好適なもの
であつえ。This notebook-shaped molded product is suitable for use as blood powder.
比較例1
カルシウム・亜鉛系安定剤 1.5重量部エ
ポキシ化大豆油 10重量部上記
組成物から実施例1と同様にしてシート状成形物を得た
。Comparative Example 1 Calcium/zinc stabilizer 1.5 parts by weight Epoxidized soybean oil 10 parts by weight A sheet-shaped molded product was obtained from the above composition in the same manner as in Example 1.
Claims (1)
ビニル共重合体を含有する組成物に&いて、エチレン・
−酸化炭素・酢酸ビニル共重合体として、エチレンe−
酸化炭嵩・酢酸ビニル共重合体に対して薯解性がなく酢
酸に対して一解性がある液体によ)予じめ部層しえもa
t使用することを螢黴とす為、医療I11#用樹脂銀威
物 L 組成物が酸化カルシウム黴粉末又は(及び)酸化マ
ダネシクム黴輪末を含有することを特徴とする特許請求
O聰11項記載Oli療器材用威彫物OII造方法[Claims] 1. A composition containing a vinyl chloride resin and an ethylene-carbon oxide-vinyl acetate copolymer;
- As a carbon oxide/vinyl acetate copolymer, ethylene e-
A liquid that is not degradable to oxidized carbon/vinyl acetate copolymer and monolytic to acetic acid) is pre-layered.
Patent claim O 11, characterized in that the composition contains calcium oxide mold powder or (and) Madaneshicum oxide mold powder. Described Oli method for making Oli majestic carvings for medical equipment
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57041889A JPS58157469A (en) | 1982-03-16 | 1982-03-16 | Resin composition for medical device |
US06/474,349 US4495312A (en) | 1982-03-16 | 1983-03-11 | Resin composition suitable for use in medical devices |
CA000423467A CA1207489A (en) | 1982-03-16 | 1983-03-11 | Resin composition suitable for use in medical devices |
KR1019830000996A KR910008581B1 (en) | 1982-03-16 | 1983-03-12 | Resin Compositions for Medical Equipments (醫療 器材 用 樹脂 組成 物) |
EP83301467A EP0089243B1 (en) | 1982-03-16 | 1983-03-16 | Resin composition suitable for use in medical devices |
DE8383301467T DE3370348D1 (en) | 1982-03-16 | 1983-03-16 | Resin composition suitable for use in medical devices |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57041889A JPS58157469A (en) | 1982-03-16 | 1982-03-16 | Resin composition for medical device |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58157469A true JPS58157469A (en) | 1983-09-19 |
JPS6351027B2 JPS6351027B2 (en) | 1988-10-12 |
Family
ID=12620843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57041889A Granted JPS58157469A (en) | 1982-03-16 | 1982-03-16 | Resin composition for medical device |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58157469A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01221161A (en) * | 1988-02-29 | 1989-09-04 | Terumo Corp | Medical device and manufacture thereof |
JP2006152112A (en) * | 2004-11-29 | 2006-06-15 | Mitsubishi Plastics Ind Ltd | Vinyl chloride-based copolymer composition and molded product of the same |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6135594A (en) * | 1998-12-21 | 2000-10-24 | Johnson & Johnson Vision Care, Inc. | Toric contact lens with axis offset compensation and method and apparatus for manufacturing same |
-
1982
- 1982-03-16 JP JP57041889A patent/JPS58157469A/en active Granted
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01221161A (en) * | 1988-02-29 | 1989-09-04 | Terumo Corp | Medical device and manufacture thereof |
JP2006152112A (en) * | 2004-11-29 | 2006-06-15 | Mitsubishi Plastics Ind Ltd | Vinyl chloride-based copolymer composition and molded product of the same |
Also Published As
Publication number | Publication date |
---|---|
JPS6351027B2 (en) | 1988-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4401536A (en) | Biocompatible, steam-sterilizable irradiated articles comprised of ethylene copolymer and polypropylene blends | |
CA1207489A (en) | Resin composition suitable for use in medical devices | |
JPS58157469A (en) | Resin composition for medical device | |
JP2003082250A (en) | Water-absorbing resin composition and method for producing the same | |
JP2009051895A (en) | Antibacterial foam resin | |
JPS6350018B2 (en) | ||
JPS5854957A (en) | Production of molded substance for medical device | |
JPH02212536A (en) | Resin composition for medical material | |
JPS6351032B2 (en) | ||
JPS6096623A (en) | Production of resin molding | |
JPS6157787B2 (en) | ||
JPS6351028B2 (en) | ||
JPS5850964A (en) | Resin composition for medical device | |
JPS6351029B2 (en) | ||
JPS6351030B2 (en) | ||
JPH0728918B2 (en) | Blood or infusion treatment material | |
JPS6330941B2 (en) | ||
Ignatious et al. | X-ray contrast polymers containing miscible organobismuth compounds | |
JPS6350019B2 (en) | ||
JPS62106768A (en) | Resin composition for medical material | |
JPS5969079A (en) | Resin composition for medical device | |
JPS6041945B2 (en) | Resin composition for medical equipment | |
JPS6033143B2 (en) | Moisture-sensitive conductive molding polymer composition | |
JPS61154568A (en) | Blood or infusion liquid treatment material | |
JPS5849154A (en) | Production of resin composition for medical device |